Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin 29 pseudogene 2 is a pseudogene found in humans on chromosome 16p11.2. It is annotated as a non-protein-coding locus and is not considered to encode a functional protein. The gene has been referred to as RUN domain-containing protein 2C and Putative protein SNX29P2, but there is no evidence that these aliases reflect a protein product in vivo.[2][5][6] Pseudogenes like SNX29P2 typically arise from duplication or retrotransposition events of protein-coding genes (in this case, Sorting nexin 29), but accumulate mutations that render them non-functional. As a pseudogene, SNX29P2 is not a therapeutic target, does not encode a receptor, enzyme, or other druggable entity, and has no known biological or disease-modifying function. No associated drugs, mechanisms of action, biomarkers, or safety concerns are documented. The molecule should not be considered a valid target for drug discovery or therapeutic intervention, and reporting as a drug target is incorrect.[2][5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin 29 pseudogene 2 (SNX29P2).